CP-724,714 in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: CP-724,714
Sponsor: Jonsson Comprehensive Cancer Center
Collaborators: Pfizer